Implantable Pulse Generator Market Report 2024: Innovations in Neuromodulation and Growth Trends

"Gain a competitive edge with up to 30% off in-depth market reports-uncover key trends, growth drivers, and forecasts today!

The new report published by The Business Research Company, titled Implantable Pulse Generator Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the implantable pulse generator market size has grown strongly in recent years. It will grow from $99.52 billion in 2023 to $107.09 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The implantable pulse generator market size is expected to see strong growth in the next few years. It will grow to $144.31 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%.

Download Free Sample Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=18639&type=smp

What Is Driving The Growth Of The Global Implantable Pulse Generator Market?

Impact Of Neurological Disorders On Implantable Pulse Generator Market Growth
A rise in the incidence of neurological disorders is expected to propel the growth of the implantable pulse generator market going forward. Neurological disorders refer to conditions affecting the brain, spinal cord, and nervous system, impacting functions such as movement, sensation, and cognition. Increasing cases of neurological disorders are often attributed to factors such as aging populations, lifestyle changes, environmental influences, and improved diagnostic techniques. Implantable pulse generators help with neurological disorders by delivering targeted electrical impulses to modulate abnormal neural activity and alleviate symptoms. For instance, in December 2022, according to the Parkinson Foundation, a US-based nonprofit organization, by 2020, there were 930,000 individuals in the U.S. with Parkinson's disease (PD), and this number is projected to grow to 1.2 million by 2030. Therefore, the rise in the incidence of neurological disorders is driving the growth of the implantable pulse generator market.

What Is The Key Trend In The Global Implantable Pulse Generator Market?

Advancements In Neuromodulation Technology Enhanced Implantable Pulse Generators Market
Major companies operating in the implantable pulse generator market are increasing their focus on developing advanced neuromodulation devices to enhance treatment efficacy, improve patient outcomes, and expand the applicability of these devices across a broader range of neurological conditions. A neuromodulation device is a medical device designed to alter nerve activity by delivering electrical or pharmaceutical agents directly to targeted areas of the nervous system. For instance, in November 2022, CVRx Inc., a US-based medical device company, launched the new Barostim NEO2 IPG, an implantable pulse generator for patients undergoing therapy. The Barostim system uses neuromodulation to improve heart failure symptoms by delivering electrical pulses to the baroreceptors in the carotid artery wall. This stimulation activates the body's baroreflex, triggering an autonomic response in the heart. The therapy aims to restore balance to the autonomic nervous system and alleviate heart failure symptoms.

How Is The Global Implantable Pulse Generator Market Segmented?
The implantable pulse generator market covered in this report is segmented -

1) By Product: Implantable Cardiac Pacemakers, Implantable Defibrillators, Cochlear Implants, Implantable Nerve Stimulators (Fes), Implantable Infusion Pumps, Implantable Active Monitoring Devices
2) By Charging Type: Rechargeable, Non Rechargeable
3) By Application: Cardiovascular Diseases, Movement Disorders, Orthopedic Diseases, Other Applications
4) By End User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics

You Can Pre-Book The Global Market Report Of Your Requirement For A Swift Delivery And Also Get An Exclusive Discount On This Report, Checkout Link:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18639

How Is The Competitive Landscape Of The Global Implantable Pulse Generator Market?
Major companies operating in the implantable pulse generator market are Abbott Laboratories, Medtronic PLC, Boston Scientific Corporation, Integer Holdings Corporation, Livanova plc, Inspire Medical Systems Inc., Nevro Corp, Impulse Dynamics Ltd., Valtronic Inc., NeuroPace Inc., SPR Therapeutics Inc., Stimwave LLC, SetPoint Medical, ReShape Lifesciences Inc., Synapse Biomedical Inc., Nuvectra Medical Inc., NeuroSigma Inc., Nalu Medical Inc., MainStay Medical International PLC, Dextronix Inc., BioControl Medical Inc.

Contents Of The Global Implantable Pulse Generator Market
1. Executive Summary
2. Implantable Pulse Generator Market Report Structure
3. Implantable Pulse Generator Market Trends And Strategies
4. Implantable Pulse Generator Market - Macro Economic Scenario
5. Implantable Pulse Generator Market Size And Growth
…..
27. Implantable Pulse Generator Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore The Report Store To Make A Direct Purchase Of The Report: https://www.thebusinessresearchcompany.com/report/implantable-pulse-generator-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.